US News

U.S. FDA delays decision on Moderna’s COVID-19 vaccine for adolescents – WSJ

Published by
Reuters

(Reuters) -The U.S. health regulator is delaying its decision on authorizing Moderna Inc’s COVID-19 vaccine for adolescents to check if the shot could increase the risk of a rare inflammatory heart condition, the Wall Street Journal reported on Friday. The U.S. Food and Drug Administration (FDA) has been inspecting the risk of the condition, myocarditis, among younger men vaccinated with Moderna’s shot, especially versus Pfizer’s vaccine, after certain Nordic countries limited use of the shot, the report https://on.wsj.com/3p3P5Zp said, citing people familiar with the matter. The agency has no…

Read More

Facebook Comments

Check Also

Biden travels to Missouri to highlight U.S. infrastructure law

Published by Reuters By Trevor Hunnicutt Kansas City, ...

Archives